Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs.

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Szymon Mielczarek

Institute of Cardiology in Anin, Warsaw (Poland)

9 More presentations in this session

Presentation thumbnail

Future risk of bradyarrhythmias in patients with hypertrophic cardiomyopathy and implantable cardioverter defibrillator indication

Doctor K. Nakasuka (Suita, JP)

Abstract Slides

Presentation thumbnail

Dilated cardiomyopathy - a group that does not benefit from ICD?

Doctor P. Silverio Antonio (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Professor G. Frommeyer (Munster, DE)

Presentation thumbnail

Incidence of appropriate implantable cardioverter defibrillator therapy and sudden cardiac death in cardiac sarcoidosis - a systematic review and meta-analysis

Mr K. Franke (Adelaide, AU)

Abstract Slides

Presentation thumbnail

Predicting arrhythmic risk in dilated cardiomyopathy: a systematic review & meta-analysis of clinical parameters

Doctor A. Sammani (Utrecht, NL)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 1 - Arrhythmia in cardiomyopathy

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy

Congress Session

Risk assessment and prevention of sudden cardiac death in cardiomyopathies

Congress Session

Gaps in risk stratification for patients with structural heart disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources